<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>赛柏蓝 | wechat-feeds</title><link>http://MjM5NTA4Mzc2Mg.favicon.privacyhide.com/favicon.ico</link><description>赛柏蓝（Mic366）,中国医药行业专业的资讯信息分享互动平台，致力于及时、准确、有用！</description><managingEditor> (hellodword)</managingEditor><pubDate>Sun, 28 Mar 2021 21:27:30 +0800</pubDate><image><url>http://MjM5NTA4Mzc2Mg.favicon.privacyhide.com/favicon.ico</url><title>赛柏蓝 | wechat-feeds</title><link>http://MjM5NTA4Mzc2Mg.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>11省联盟带量采购来了（附详细报量数据）</title><link>https://mp.weixin.qq.com/s/kqtWosqQbwFmtJ4cp1PclA</link><description></description><content:encoded><![CDATA[11省联盟带量采购来了（附详细报量数据）]]></content:encoded><pubDate>Sun, 28 Mar 2021 19:20:33 +0800</pubDate></item><item><title>重磅产品，连续五年市场第一</title><link>https://mp.weixin.qq.com/s/_Dv9oJzBHJBQWnGO8M1Cvw</link><description></description><content:encoded><![CDATA[重磅产品，连续五年市场第一]]></content:encoded><pubDate>Sun, 28 Mar 2021 19:20:33 +0800</pubDate></item><item><title>医保谈判产品，进院难了</title><link>https://mp.weixin.qq.com/s/nJryXyddNyZtnrSqmYKMNQ</link><description></description><content:encoded><![CDATA[医保谈判产品，进院难了]]></content:encoded><pubDate>Sun, 28 Mar 2021 19:20:33 +0800</pubDate></item><item><title>17家药业最新收入情况公布</title><link>https://mp.weixin.qq.com/s/gojP5sYfMRtQxBIqQt86Yw</link><description></description><content:encoded><![CDATA[17家药业最新收入情况公布]]></content:encoded><pubDate>Sun, 28 Mar 2021 19:20:33 +0800</pubDate></item><item><title>区县市场大爆发，这一药品销售超30亿</title><link>https://mp.weixin.qq.com/s/Nmwqe9k-tltamTldXk05_g</link><description></description><content:encoded><![CDATA[区县市场大爆发，这一药品销售超30亿]]></content:encoded><pubDate>Sun, 28 Mar 2021 19:20:33 +0800</pubDate></item><item><title>医药营销，遇到天赐良机</title><link>https://mp.weixin.qq.com/s/qwafIGNK7l2bUEHq2dC3fA</link><description></description><content:encoded><![CDATA[医药营销，遇到天赐良机]]></content:encoded><pubDate>Sun, 28 Mar 2021 19:20:33 +0800</pubDate></item><item><title>注意：药企全链条诊断，重磅来袭！</title><link>https://mp.weixin.qq.com/s/ROge5jTkbr6wZth_B8i8jw</link><description></description><content:encoded><![CDATA[注意：药企全链条诊断，重磅来袭！]]></content:encoded><pubDate>Sun, 28 Mar 2021 19:20:33 +0800</pubDate></item><item><title>关注药品创新，一批顶级专家来了</title><link>https://mp.weixin.qq.com/s/VrBCYucb1lEGou9MveBMVA</link><description></description><content:encoded><![CDATA[关注药品创新，一批顶级专家来了]]></content:encoded><pubDate>Sun, 28 Mar 2021 19:20:33 +0800</pubDate></item><item><title>第五轮国采，时间传出</title><link>https://mp.weixin.qq.com/s/6OgVKKesRNh-KlqwqyP-9Q</link><description></description><content:encoded><![CDATA[第五轮国采，时间传出]]></content:encoded><pubDate>Sat, 27 Mar 2021 18:54:33 +0800</pubDate></item><item><title>第四批国采执行，最新通知来了</title><link>https://mp.weixin.qq.com/s/xDhs4vPp63KIghBIMt77Cg</link><description></description><content:encoded><![CDATA[第四批国采执行，最新通知来了]]></content:encoded><pubDate>Sat, 27 Mar 2021 18:54:33 +0800</pubDate></item><item><title>恒瑞：17个品种有望首仿</title><link>https://mp.weixin.qq.com/s/XS1ztAwpGGi3gIYLgfi1YA</link><description></description><content:encoded><![CDATA[恒瑞：17个品种有望首仿]]></content:encoded><pubDate>Sat, 27 Mar 2021 18:54:33 +0800</pubDate></item><item><title>中国医保研究报告，发布了</title><link>https://mp.weixin.qq.com/s/bfrT5MO8rNt_w4wq0aCMyQ</link><description></description><content:encoded><![CDATA[中国医保研究报告，发布了]]></content:encoded><pubDate>Sat, 27 Mar 2021 18:54:33 +0800</pubDate></item><item><title>一批药企火力全开做DTP：国控、上药...</title><link>https://mp.weixin.qq.com/s/OFrMpRdnkxq1RcoZmWHUSA</link><description></description><content:encoded><![CDATA[一批药企火力全开做DTP：国控、上药...]]></content:encoded><pubDate>Sat, 27 Mar 2021 18:54:33 +0800</pubDate></item><item><title>医药营销，也有一条龙服务</title><link>https://mp.weixin.qq.com/s/7E5lr90kAY42HxB5z2G6Vg</link><description></description><content:encoded><![CDATA[医药营销，也有一条龙服务]]></content:encoded><pubDate>Sat, 27 Mar 2021 18:54:33 +0800</pubDate></item><item><title>千亿糖尿病市场，有械企加码</title><link>https://mp.weixin.qq.com/s/O_QCUGz6irS5Kb5YIfCBjg</link><description></description><content:encoded><![CDATA[千亿糖尿病市场，有械企加码]]></content:encoded><pubDate>Sat, 27 Mar 2021 18:54:33 +0800</pubDate></item><item><title>一批高质量品种将上市：潜力大、竞品少...</title><link>https://mp.weixin.qq.com/s/KqkD9SgghglNm00bAPrm1g</link><description></description><content:encoded><![CDATA[一批高质量品种将上市：潜力大、竞品少...]]></content:encoded><pubDate>Sat, 27 Mar 2021 18:54:33 +0800</pubDate></item><item><title>一批医药代表将出局</title><link>https://mp.weixin.qq.com/s/7m1zM21sc0c4U7K_JkFfcg</link><description></description><content:encoded><![CDATA[一批医药代表将出局]]></content:encoded><pubDate>Fri, 26 Mar 2021 18:39:17 +0800</pubDate></item><item><title>两家知名大三甲，部分停诊</title><link>https://mp.weixin.qq.com/s/M5oEUJw0PuqbCs6pY0DE_w</link><description></description><content:encoded><![CDATA[两家知名大三甲，部分停诊]]></content:encoded><pubDate>Fri, 26 Mar 2021 18:39:17 +0800</pubDate></item><item><title>恒瑞PD-1，新适应症来了</title><link>https://mp.weixin.qq.com/s/94wlVacdYrKnzW2GpVANoA</link><description></description><content:encoded><![CDATA[恒瑞PD-1，新适应症来了]]></content:encoded><pubDate>Fri, 26 Mar 2021 18:39:17 +0800</pubDate></item><item><title>这三家药企真磨人</title><link>https://mp.weixin.qq.com/s/kGM0WSdMgk2uFYyWqPB4OQ</link><description></description><content:encoded><![CDATA[这三家药企真磨人]]></content:encoded><pubDate>Fri, 26 Mar 2021 18:39:17 +0800</pubDate></item></channel></rss>